Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EBT (2019 - 2025)

Korro Bio's EBT history spans 7 years, with the latest figure at $68.4 million for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 423.36% year-over-year to $68.4 million, compared with a TTM value of $1.2 million through Dec 2025, up 101.43%, and an annual FY2025 reading of $1.2 million, up 101.43% over the prior year.
  • EBT for Q4 2025 was $68.4 million at Korro Bio, up from -$18.1 million in the prior quarter.
  • The five-year high for EBT was $68.4 million in Q4 2025, with the low at -$25.8 million in Q2 2025.
  • Average EBT over 5 years is -$15.3 million, with a median of -$20.7 million recorded in 2021.
  • Year-over-year, EBT crashed 509.77% in 2023 and then surged 423.36% in 2025.
  • Tracing KRRO's EBT over 5 years: stood at -$21.5 million in 2021, then surged by 128.86% to $6.2 million in 2022, then crashed by 509.77% to -$25.4 million in 2023, then rose by 16.79% to -$21.2 million in 2024, then surged by 423.36% to $68.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's EBT are $68.4 million (Q4 2025), -$18.1 million (Q3 2025), and -$25.8 million (Q2 2025).